COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN PORTUGAL

被引：0
|
作者：
Mateus, C. [1 ]
Moura, A. [1 ]
机构：
[1] Univ Nova Lisboa, Escola Nacl Saude Publ, P-1200 Lisbon, Portugal
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2616
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS46
引用
收藏
页码：A380 / A381
页数：3
相关论文
共 50 条
  • [21] Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK
    Alex Diamantopoulos
    A. Finckh
    T. Huizinga
    D. K. Sungher
    L. Sawyer
    D. Neto
    F. Dejonckheere
    [J]. PharmacoEconomics, 2014, 32 : 775 - 787
  • [22] Cost-effectiveness analysis of tofacitinib compared with adalimumab and etanercept in the treatment of severe active rheumatoid arthritis; Iranian experience
    Fatemi, Behzad
    Rezaei, Soheila
    Taheri, Saeed
    Peiravian, Farzad
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (04) : 775 - 784
  • [23] Cost-effectiveness Analysis of Treatment Sequence Initiating With Etanercept Compared With Leflunomide in Rheumatoid Arthritis: Impact of Reduced Etanercept Cost With Patent Expiration in South Korea
    Park, Sun-Kyeong
    Park, Seung-Hoo
    Lee, Min-Young
    Park, Ji-Hyun
    Jeong, Jae-Hong
    Lee, Eui-Kyung
    [J]. CLINICAL THERAPEUTICS, 2016, 37 (11) : 2430 - 2446
  • [24] The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis
    Vergel, Y. Bravo
    Hawkins, N. S.
    Claxton, K.
    Asseburg, C.
    Palmer, S.
    Woolacott, N.
    Bruce, I. N.
    Sculpher, M. J.
    [J]. RHEUMATOLOGY, 2007, 46 (11) : 1729 - 1735
  • [25] A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
    Chen, Y-F
    Jobanputra, P.
    Barton, P.
    Jowett, S.
    Bryan, S.
    Clark, W.
    Fry-Smith, A.
    Burls, A.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (42) : 1 - +
  • [26] Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis (RA) in the UK.
    Brennan, A
    Bansback, N
    Conway, P
    Reynolds, AV
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S157 - S157
  • [27] COST-EFFECTIVENESS ANALYSIS OF THE TREATMENT OF RHEUMATOID-ARTHRITIS - FEASIBILITY STUDY
    PETTINGILL, BF
    [J]. CLINICAL RESEARCH, 1980, 28 (01): : A149 - A149
  • [28] ABATACEPT FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN ARGENTINA: A COST-EFFECTIVENESS ANALYSIS
    Elgart, J. F.
    Gonzalez, L.
    Aiello, E. C.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A223 - A224
  • [29] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT AS FIRST LINE OF TREATMENT IN COLOMBIAN PATIENTS WITH PSORIATIC ARTHRITIS
    Castano Gamboa, N.
    Reyes, J.
    Huerfano, C.
    Rodriguez, A.
    [J]. VALUE IN HEALTH, 2018, 21 : S297 - S297
  • [30] THE COST-EFFECTIVENESS OF ALTERNATIVE TREATMENT SEQUENCES IN RHEUMATOID ARTHRITIS
    Trueman, D.
    Bird, A.
    Mumby-Croft, J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A48 - A48
12345